MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden.
about
Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.CXCL1 microspheres: a novel tool to stimulate arteriogenesis.IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis.Transflammation: Innate immune signaling in nuclear reprogramming.A protective role of IRF3 and IRF7 signalling downstream TLRs in the development of vein graft disease via type I interferons.Editorial highlights from Cardiovascular Research.
P2860
MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@ast
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@en
type
label
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@ast
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@en
prefLabel
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@ast
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@en
P2093
P2860
P356
P1476
MAb therapy against the IFN-α/ ...... ancing atherosclerotic burden.
@en
P2093
Anton J Horrevoets
Jan-Quinten Mol
Marieke C Boshuizen
Marion J Gijbels
Maurits R Hollander
Menno P de Winther
Niels van Royen
Nina W van der Hoeven
Paul F A Teunissen
Paul S Biesbroek
P2860
P304
P356
10.1093/CVR/CVV138
P577
2015-05-01T00:00:00Z